Apervita, the leading platform for performance-based collaboration in healthcare, today announced the acquisition of Boston-based Qcentive, a leader in value-based contract and alternative payment administration solutions for healthcare organizations.
|
CHICAGO, Aug. 13, 2019 /PRNewswire/ -- Apervita, the leading platform for performance-based collaboration in healthcare, today announced the acquisition of Boston-based Qcentive, a leader in value-based contract and alternative payment administration solutions for healthcare organizations. The combined Apervita-Qcentive solutions will integrate clinical and financial insights into a single, secure platform to enable healthcare organizations to create value-based contracts that drive greater efficiency and quality of care.
"Qcentive is the perfect complement to Apervita," said Paul Magelli, CEO of Apervita. "Apervita has focused on performance measurement and improvement for providers and plans, including the ability to engage providers directly in their workflow. Qcentive's focus on performance-based contracts between plans and providers and their associated economics is a natural extension." "Value-based relationships are critical building blocks to changing the way we buy and sell healthcare," said Christopher Pilkington, co-founder and CEO of Qcentive. "Linking plans and providers through a trusted secure platform that aligns incentives across quality, efficiency and consumer satisfaction is absolutely essential. The Apervita-Qcentive combination is the first healthcare industry platform with the ingredients to make that happen at scale." Qcentive was launched in 2016 by Blue Cross Blue Shield of Massachusetts, a nationally recognized leader for value-based payment innovation. BCBSMA has engaged Apervita and will continue to be a customer of Qcentive technologies. "Several years ago, we realized we needed a cloud-based analytics solution to make it easier to navigate the complex demands of a new generation of value-based contracts," said Patrick Gilligan, executive vice president of sales, marketing and product for BCBSMA and CEO of its venture investment subsidiary, Zaffre Investments. "Not finding a solution in the market, we incubated Qcentive with the intent of sharing its innovations with the broader market. The combination of Apervita and Qcentive makes this vision a reality." Value-based contracts align financial and clinical quality incentives between healthcare insurance plans and hospitals, physicians, and other clinicians. These contracts establish metrics to measure the quality of care that consumers receive. BCBSMA's Alternative Quality Contract, one of the largest and longest-running value-based models in the country, has substantially moderated cost growth while producing significant improvements in the quality of patient care, a recent Harvard Medical School study found. Qcentive was designed to allow other healthcare organizations to create their own value-based models. It provides detailed insights into the quality of clinical care and financial results to both payers and providers on a continuous, year-round basis. The combined Apervita and Qcentive entity will operate under the Apervita brand with offices in Chicago and Boston. About Apervita About Qcentive About Blue Cross Blue Shield of Massachusetts For further information, contact:
SOURCE Apervita |
View original content to download multimedia:
